Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saeed Bohlega

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Cell Death and Differentiation|June 17, 2017
The ALS-linked E102Q mutation in Sigma receptor-1 leads to ER stress-mediated defects in protein homeostasis and dysregulation of RNA-binding proteinsAlice Dreser, Jan Tilmann Vollrath, Antonio Sechi, et al.
Scientific Reports|March 6, 2019
Integrated Analysis of Whole Exome Sequencing and Copy Number Evaluation in Parkinson's DiseaseEman Al Yemni, Dorota Monies, Thamer Alkhairallah, et al.
Nature Genetics|September 6, 2003
Mutations in NHLRC1 cause progressive myoclonus epilepsyElayne M Chan, Edwin J Young, Leonarda Ianzano, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 16, 2015
Strategies for treatment of dystoniaDirk Dressler, Eckart Altenmueller, Roongroj Bhidayasiri, et al.
CNS Drugs|January 27, 2026
Consensus Recommendations for the Diagnosis and Treatment of Neuromyelitis Optica Spectrum Disorders (NMOSD): The MENACTRIMS GuidelinesBassem Yamout, Riadh Gouider, Raed Al-Roughani, et al.
American Journal of Human Genetics|November 26, 2008
Mutations in C2orf37, encoding a nucleolar protein, cause hypogonadism, alopecia, diabetes mellitus, mental retardation, and extrapyramidal syndromeAnas M Alazami, Amr Al-Saif, Abdulaziz Al-Semari, et al.
Journal of Movement Disorders|June 13, 2023
Nine Hereditary Movement Disorders First Described in Asia: Their History and EvolutionPriya Jagota, Yoshikazu Ugawa, Zakiyah Aldaajani, et al.
Journal of Neurology|October 28, 2016
Botulinum toxin therapy for treatment of spasticity in multiple sclerosis: review and recommendations of the IAB-Interdisciplinary Working Group for Movement Disorders task forceDirk Dressler, Roongroj Bhidayasiri, Saeed Bohlega, et al.
Journal of Neurology|February 10, 2018
Defining spasticity: a new approach considering current movement disorders terminology and botulinum toxin therapyDirk Dressler, Roongroj Bhidayasiri, Saeed Bohlega, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|February 26, 2021
Consensus guidelines for botulinum toxin therapy: general algorithms and dosing tables for dystonia and spasticityDirk Dressler, Maria Concetta Altavista, Eckart Altenmueller, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Cell Death and Differentiation|June 17, 2017
The ALS-linked E102Q mutation in Sigma receptor-1 leads to ER stress-mediated defects in protein homeostasis and dysregulation of RNA-binding proteinsAlice Dreser, Jan Tilmann Vollrath, Antonio Sechi, et al.
Scientific Reports|March 6, 2019
Integrated Analysis of Whole Exome Sequencing and Copy Number Evaluation in Parkinson's DiseaseEman Al Yemni, Dorota Monies, Thamer Alkhairallah, et al.
Nature Genetics|September 6, 2003
Mutations in NHLRC1 cause progressive myoclonus epilepsyElayne M Chan, Edwin J Young, Leonarda Ianzano, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 16, 2015
Strategies for treatment of dystoniaDirk Dressler, Eckart Altenmueller, Roongroj Bhidayasiri, et al.
CNS Drugs|January 27, 2026
Consensus Recommendations for the Diagnosis and Treatment of Neuromyelitis Optica Spectrum Disorders (NMOSD): The MENACTRIMS GuidelinesBassem Yamout, Riadh Gouider, Raed Al-Roughani, et al.
American Journal of Human Genetics|November 26, 2008
Mutations in C2orf37, encoding a nucleolar protein, cause hypogonadism, alopecia, diabetes mellitus, mental retardation, and extrapyramidal syndromeAnas M Alazami, Amr Al-Saif, Abdulaziz Al-Semari, et al.
Journal of Movement Disorders|June 13, 2023
Nine Hereditary Movement Disorders First Described in Asia: Their History and EvolutionPriya Jagota, Yoshikazu Ugawa, Zakiyah Aldaajani, et al.
Journal of Neurology|October 28, 2016
Botulinum toxin therapy for treatment of spasticity in multiple sclerosis: review and recommendations of the IAB-Interdisciplinary Working Group for Movement Disorders task forceDirk Dressler, Roongroj Bhidayasiri, Saeed Bohlega, et al.
Journal of Neurology|February 10, 2018
Defining spasticity: a new approach considering current movement disorders terminology and botulinum toxin therapyDirk Dressler, Roongroj Bhidayasiri, Saeed Bohlega, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|February 26, 2021
Consensus guidelines for botulinum toxin therapy: general algorithms and dosing tables for dystonia and spasticityDirk Dressler, Maria Concetta Altavista, Eckart Altenmueller, et al.
Pageof 7